List view / Grid view

Fred Fiedorek

 

news

U.S. FDA grants priority review for Metreleptin

Metreleptin, an investigational agent for treatment of metabolic disorders associated…

4 June 2013 | By Bristol-Myers Squibb Company

Metreleptin, an investigational agent for treatment of metabolic disorders associated with rare forms of LD...